SCM
AGIO icon

Sterling Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Sterling Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$42.2K Sell
1,136
-735
-39% -$22.3K ﹤0.01% 1629
2026
Q1 		$63.3K Sell
1,871
-1,412
-43% -$40K ﹤0.01% 1545
2025
Q4 		$89.4K Sell
3,283
-628
-16% -$22K ﹤0.01% 1574
2025
Q3 		$157K Buy
3,911
+2,396
+158% +$90.1K ﹤0.01% 1394
2025
Q2 		$50.4K Buy
1,515
+540
+55% +$16.4K ﹤0.01% 1505
2025
Q1 		$28.6K Sell
975
-806
-45% -$26.7K ﹤0.01% 1553
2024
Q4 		$58.5K Buy
1,781
+1,587
+818% +$74.6K ﹤0.01% 1571
2024
Q3 		$8.62K Buy
+194
New +$8.81K ﹤0.01% 1600
2015
Q2 		– Sell
-2,677
Closed -$252K – 874
2015
Q1 		$252K Buy
+2,677
New +$300K ﹤0.01% 810

Other funds holding AGIO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Sterling Capital Management's AGIO Position: Q2 2026 in Review

Sterling Capital Management reduced its Agios Pharmaceuticals (AGIO) stake by 39% in Q2 2026, selling an estimated $22.3K and leaving 1,136 shares worth $42.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1629.

Sterling Capital Management first reported a position in AGIO in Q1 2015 and has held it in 9 quarters since. The position peaked at $252K in Q1 2015. 239 funds tracked by Wall St. Rank hold AGIO as of Q2 2026.

  • Sterling Capital Management held 1,136 shares of Agios Pharmaceuticals worth $42.2K as of Q2 2026.
  • Sterling Capital Management sold 735 Agios Pharmaceuticals shares in Q2 2026, an estimated $22.3K.
  • Agios Pharmaceuticals made up ﹤0.01% of Sterling Capital Management's portfolio in Q2 2026, its #1629 holding.
  • Sterling Capital Management first reported a position in Agios Pharmaceuticals in Q1 2015 and has held it in 9 quarters since.
  • Sterling Capital Management's Agios Pharmaceuticals position peaked at $252K in Q1 2015.
  • 239 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q2 2026.

Based on Sterling Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.